iScience · 2022 · 48 citations · 32 references
Life SciencesCell BiologyMolecular BiologyGene ExpressionInflammationInnate ImmunityFibrosisHepatic FibrosisHepatic PathophysiologyLiver DiseaseMicrorna BiologyMicrorna-mediated RegulationActivated Hepatic Stellate CellsExosomesHepatic Stellate Cell BiologyLiver Fibrosis ProgressionMacrophage-mediated FibrosisMicrorna Regulation Of FibrogenesisNonalcoholic Steatohepatitis Associated FibrosisRna Sequencing (Rna-seq)
Liver fibrosis is a severe stage of nonalcoholic fatty liver disease (NAFLD), which is closely associated with the activation of hepatic stellate cells (HSCs) and their interaction with macrophages. Exosomes can mediate crosstalk between macrophages and HSCs in NAFLD-associated fibrosis. We found that M2 macrophage-derived exosomes significantly inhibit HSCs activation. RNA-seq studies revealed that miRNA-411-5p was decreased in serum exosomes of nonalcoholic steatohepatitis (NASH) patients as compared with that in healthy controls. Besides, miR-411-5p and M2 macrophage markers are decreased in the liver of the NASH model. We further proved that exosomal miR-411-5p from M2 macrophages inhibit HSCs activation and miR-411-5p directly downregulated the expression of Calmodulin-Regulated Spectrin-Associated Protein 1 (CAMSAP1) to inactivate stellate cells. Importantly, knockdown of CAMSAP1 also inhibited HSCs activation. This study contributes to understanding the underlying mechanism of HSCs activation and indicates CAMSAP1 may serve as a potential therapeutic target for NASH.
32
Clotilde Théry, Kenneth W. Witwer, Elena Aïkawa et al. · Journal of Extracellular Vesicles · 2018 · 11.2K citations · Full text
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura, Yuzo Kodama, Sayaka Inokuchi et al. · Gastroenterology · 2010 · 731 citations · Full text
Life Sciences, Immunology, Pathology +14